OptumRx Adds AxelaCare to Enhance Pharmacy Care Services for Patients

Home infusion innovator complements OptumRx’s specialty pharmacy
offering

Strengthens care integration and clinical services for patients with
complex medical conditions

EDEN PRAIRIE, Minn. & LENEXA, Kan.–(BUSINESS WIRE)–OptumRx, the pharmacy care services business of Optum, announced it has
acquired AxelaCare Health Solutions, a leading provider of home infusion
solutions. The addition of AxelaCare continues OptumRx’s strategy of
improving care and reducing costs by integrating information and
services on behalf of those it serves.

With an aging population accessing new and more medications, AxelaCare
enhances OptumRx’s ability to deliver the best care to the growing
number of consumers managing complex conditions through at-home
infusions. Together, AxelaCare and OptumRx will expand the scope of
treatments that can be offered in the home rather than in higher-cost
institutional settings.

AxelaCare’s industry-first electronic patient outcomes assessment
technology, CareExchange® captures and reports real-time
patient-specific data on the clinical efficacy of drug regimens.
CareExchange will work together with Optum’s analytics tools to support
treatment decisions and OptumRx’s synchronized approach to medical and
pharmacy care.

“AxelaCare’s at-home services will enable us to more effectively support
the growing number of people managing complex conditions, many of whom
require infusions that increasingly involve higher-cost specialty
medications,” said Mark Thierer, CEO of OptumRx. “We look forward to
adding AxelaCare’s broad spectrum of therapy solutions to bring
consumers higher-quality, more cost-effective infusion service at home,
where we know they prefer to get well and stay well.”

Larry Renfro, chief executive officer of Optum said “AxelaCare’s
sophisticated approach to treating patients with complex clinical
conditions will be further enhanced by Optum’s ability to deliver more
actionable information to the precise point of care, yielding greater
value for customers and consumers.”

AxelaCare currently treats patients in 44 states and Washington, D.C.
through its network of registered nurses. The company offers chronic
drug therapies from unaffiliated manufacturers through its network of 34
pharmacies, for conditions such as autoimmune disease and hemophilia, as
well as acute infusion therapies including antibiotics and total
parenteral nutrition.

“OptumRx’s differentiated pharmacy care services model that goes beyond
prescriptions to leverage industry-leading data, technology and scale,
will help AxelaCare deliver on our promise to improve the health of the
people and communities we serve,” said Ted Kramm, CEO of AxelaCare. “Our
shared focus on creating more connected experiences will support better
treatment decisions, health outcomes and cost savings for patients and
customers.”

Through its service to more than 65 million people through a broad base
of payer and employer clients, OptumRx will accelerate the introduction
of AxelaCare’s progressive approach to home infusion care to a broader
market.

About OptumRx and Optum

OptumRx is an innovative pharmacy care services company managing the
prescription drug benefits of commercial, Medicare, Medicaid and other
government health plans, as well as those of employers and unions
through a national network of 67,000 community pharmacies and
state-of-the-art home delivery pharmacies which have earned the
prestigious Verified Internet Pharmacy Practice Sites™ (VIPPS)
accreditation by the National Association of Boards of Pharmacy. OptumRx
is part of Optum, a leading information and technology-enabled health
services business dedicated to making the health system work better for
everyone. Visit www.optum.com
for more information about OptumRx. Optum is the technology-enabled
health services business of UnitedHealth Group (NYSE:UNH), serving
approximately 300 payers and nearly 115 million individuals.

Click
here to subscribe to Mobile Alerts for UnitedHealth Group.

Contacts

Optum
Drew Krejci, 952-205-6652
andrew.krejci@optum.com